Avalo Therapeutics
AVTX
AVTX
53 hedge funds and large institutions have $131M invested in Avalo Therapeutics in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+1
Holders Change %
+1.92%
% of All Funds
0.94%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
21
Reduced
11
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
OM
Opaleye Management
Boston,
Massachusetts
|
$6.92M |
2 |
Two Sigma Investments
New York
|
$1.25M |
3 |
SCM
Sio Capital Management
New York
|
$2.45M |
4 |
Renaissance Technologies
New York
|
$284K |
5 |
Two Sigma Advisers
New York
|
$986K |